Previous 10 | Next 10 |
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Anavex To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 5, 2024) - Faruqi & Faruqi, LLP, a leading national secur...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Anavex To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 4, 2024) - Faruqi & Faruqi, LLP, a leading national secur...
NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders i...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Anavex To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 2, 2024) - Faruqi & Faruqi, LLP, a leading national secur...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Anavex To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - April 28, 2024) - Faruqi & Faruqi, LLP, a leading national se...
NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Anavex Life Sciences Corporation (NASDAQ: AVXL)? Did you purchase your shares between February 1, 2022 and January 1, 2024, inclusive? Did you lose money in your in...
Do you, or did you, own shares of Anavex Life Sciences Corporation (NASDAQ:AVXL)? Did you purchase your shares between February 1, 2022 and January 1, 2024, inclusive? Did you lose money in your investment in Anavex Life Sciences Corporation? Do you want to discuss your rights? ...
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Anavex To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - April 4, 2024) - Faruqi & Faruqi, LLP, a leading national sec...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Anavex To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - April 2, 2024) - Faruqi & Faruqi, LLP, a leading national sec...
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsyc...